Trading a ABSI straddle lets you take a pure volatility position on Absci Corp without committing to a direction. Absci Corp's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ABSI straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ABSI profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Absci Corp stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ABSI straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ABSI straddle is the cleanest expression of that view. Our scanner prices every ABSI straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ABSI straddle into a catalyst or short a ABSI straddle to harvest decay, the options straddle setups that matter are all in one place.
